Analytical Study of Dietary Supplement in Western Europe from 2023 to 2033
The consumption of dietary supplement in Western Europe is estimated to expand at a promising CAGR of 8.2% through 2033. The sales of dietary supplement in Western Europe are expected to reach a valuation of US$ 35,578.05 million by 2033, up from 16,185.60 in 2023.
Western Europe holds significant potential for manufacturers to expand their business operations. Consequently, they are diversifying their product lines, covering broader segment such as sports and energy, joint health, liver and detox, mental health, etc., to attract more customers. Additionally, leading competitors are fostering intense competition in the region by innovating more complex dietary supplement.
Attributes
Details
Industry Size of Dietary Supplement in Western Europe (2023)
US$ 16,185.60 million
Expected Industry Size of Dietary Supplement in Western Europe (2033)
US$ 35,578.05 million
Forecast CAGR between 2023 to 2033
8.2%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Top Trends Spurring Sales of Dietary Supplement in Western Europe
A seismic shift in shopping trends across Western Europe, with the rise of online retail channels, is contributing to the sales of dietary supplement. The growing number of online consumers seeking an easy and convenient shopping experience, exclusive product availability, and discounts is expected to drive sales of dietary supplement in Western Europe.
An increasing number of consumers are displaying a preference for customized and tailor-made offerings, including supplement, diet, and exercise. Dietary supplement are expected to play a critical role in furthering the concept of proactive and predictive health.
The surging density of dietary supplement manufacturers is leading to the commencement of production of distinct sports nutrition drinks to capture the population of sportspeople and fitness enthusiasts. Product specialization and pervasive loyalty for regional brands in Western Europe are leading to mergers and acquisitions.
Comparative View of Adjacent Dietary Supplement in Key Markets
The following table provides a comparative analysis of dietary supplement uptake across different important geographies, namely Western Europe, Korea, and globally. Based on the latest estimates, even though Korea demonstrates relatively greater potential for the dietary supplement business, Western Europe acquires a significant portion of the global market.
Industry Analysis of Dietary Supplement in Western Europe:
Attributes
Industry Analysis of Dietary Supplement in Western Europe
Find your sweet spots for generating winning opportunities in this market.
Country-wise Insights
Growing Importance and Consumption of Dietary Supplement among Individuals are Escalating the Industry Value in Italy
Country
Italy
Forecast CAGR % (2023 to 2033)
6.70%
Consumption rate of dietary supplement in Italy is predicted to register a CAGR of 6.70% through 2033. Following factors are appreciating the industry worth in Italy:
The growing perception of functional foods as healthy products is propelling the demand for items enriched with functional properties at competitive prices.
The expanding health-conscious population in the country, aware of the strong connection between health and diet, is increasing the consumption of dietary supplement to enhance the uptake of essential nutrients by individuals.
Increasing Expenditure on Healthcare is Casting a Brighter Light on the Business Prospects for Dietary Supplement in Germany
Country
Germany
Forecast CAGR % (2023 to 2033)
5.80%
The adoption of dietary supplement in Germany is increasing at a speed of 5.80 % CAGR through 2033. Given below are the leading factors that are pushing the sales of dietary supplement:
Surging demand for vitamins, minerals, urogenital health, and probiotics is expanding the country’s industry size of dietary supplement.
Increasing out-of-pocket expenses on healthcare are propelling demand for preventative supplement like these.
The United Kingdom is Set to Witness Robust Sales of Dietary Supplement
Country
United Kingdom
Forecast CAGR % (2023 to 2033)
7.90%
Sales of dietary supplement in the United Kingdom are predicted to expand at a CAGR of 7.90% through 2033. Following factors support product sales in this country:
Increasing consumers in the United Kingdom are leaning toward personalized nutrition and technology. Thus, impelling sales of dietary supplement among consumers residing in the country.
Improving knowledge about health and nutrition, owing to active lifestyle blogs, media telecasts, and social media, is expected to encourage sales of dietary supplement.
Emerging Beauty and Wellness Trends in the Netherlands are Pushing the Product Sales
Country
The Netherlands
Forecast CAGR % (2023 to 2033)
7.10%
Consumption of dietary supplement in the Netherlands is expected to surge at a CAGR of 7.10% through 2033. Mentioned below are the leading factors inducing sales of dietary supplement:
The high potential of dietary supplement in the country is expected to drive industry growth.
The surging value of beauty and wellness among consumers in the Netherlands is impacting the inclination toward dietary supplement.
Mounting Investment by Dietary Supplement’ Manufacturers in France to Boost Incremental Gains
Country
France
Forecast CAGR % (2023 to 2033)
6.30%
The adoption rate of dietary supplement in France is predicted to record a CAGR of 6.30% through 2033. The following factors augment the sales of dietary supplement:
Starting in January 2023, the country joined a growing movement of nations permitting the use of the term 'probiotic' in food and food supplement.
Increasing investment in the French dietary supplement industry are catalyzing industry growth. For instance, in October 2023, a France-based dietary supplement maker, NHCO Nutrition, partnered with Centric Software, a Product Lifecycle Management (PLM) expert, for data security, internationalization, and optimized communication.
Category-wise Insights
Demand for Soft Gel/ Pills Shaping the Dietary Supplement Industry in Western Europe
Leading Form
Soft Gel/ Pills
Value Share % (2023)
57.80%
The soft gels/pills segment accounts for a value share of 57.80% in 2023. The segment's growth is driven by the availability of a variety of multivitamin options in the form of soft gels and capsules. Their user-friendly format and easy consumption contribute to the increasing demand for soft gels and pills. Consumers, especially those with swallowing issues, favor soft gels and pills due to their effortless swallowability and gel-like consistency.
Cost-effectiveness, extended shelf life, and convenient packaging of soft gels and capsule supplement are also enhancing the segment's growth. Soft gels and capsules feature well-defined dosages, differentiating them from liquid dietary supplement and contributing to their greater prevalence in Europe.
Amino Acids are Tremendously Consumed Dietary Supplement in Western Europe
Leading Ingredient
Amino Acids
Value Share % (2023)
41.70%
As per our study, amino acids account for a share of 41.70% in 2023. Amino acids are recommended for patients suffering from chronic disorders like heart disease, diabetes, and cancer, as these diseases typically have a debilitating effect on the body’s ability to absorb and utilize amino acids. Additionally, the growing popularity of sports and fitness in Western Europe is fueling the consumption of amino acid supplement among athletes and gym-goers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Roadmap to Secure Future Success in Dietary Supplement in Western Europe
Private enterprises, as well as public corporations in Western Europe, are intensifying their commitment to innovation and quality, both of which are crucial to ensuring brand reputation. Leading players are emphasizing the improvement of their product offerings. In addition to this, companies are dedicating their research and development efforts to seamlessly integrate cutting-edge technologies, reflecting their dedication to providing high-quality dietary supplement.
Key Development Spurring the Sales of Dietary Supplement in Western Europe
Procter and Gamble, in November 2021, forayed into the vitamin C formulations category containing herbal ingredients and minerals by introducing products co-packaged with its well-known OTC drug brands, Vick’s DayQuil and NyQuil cold remedies. This move underscores the growing traction for merging conventional drugs with dietary supplement to develop new product offerings and serve the increasing demand for preventive healthcare measures.
Bayer released Berocca ImmunoEffervescent Tablets in June 2022. This nutritional supplement is developed to boost immunity. As per company’s claims, the product consists of ten essential minerals and vitamins C, D, A, B9, B6, and B12.
Nature's Bounty, in May 2021, introduced a marketing campaign in the United Kingdom and Ireland, meant to redefine its brand positioning. The campaign is intended to realign the firm’s message with its initial founding purpose to provide access to natural nutrition.
Probi, a Swedish probiotics firm, and Perrigo, a leading provider of self-care products, entered a pan-European agreement in February 2021 to introduce probiotic concepts. The agreement includes the release of three probiotics by Perrigo as dietary supplement in the immune and digestive areas on the basis of Probi’s scientifically validated probiotic strains.
Key Players Providing Dietary Supplement in Western Europe
GlaxoSmithKline plc
Bayer AG
Reckitt Benckiser Group PLC
Amway Corporation
Abbott Nutrition
Others
Scope of the Report
Attribute
Details
Estimated Industry Size in 2023
US$ 16,185.60 million
Projected Industry Size by 2033
US$ 35,578.05 million
Anticipated CAGR between 2023 to 2033
8.2% CAGR
Historical Analysis of Demand for Dietary Supplement in Western Europe
2018 to 2022
Demand Forecast for Dietary Supplement in Western Europe
2023 to 2033
Report Coverage of Dietary Supplement in Western Europe
Industry Size, Industry Trends, Analysis of Key Factors Influencing Dietary Supplement Adoption in Western Europe, Insights on Western Europe Players and their Industry Strategy in Western Europe, Ecosystem Analysis of Local and Regional Western Europe Providers
Key Countries Analyzed While Studying Opportunities for Dietary Supplement in Western Europe
Germany
Italy
France
United Kingdom
Spain
The Netherlands
BENELUX
Rest of Western Europe
Key Companies Profiled for Dietary Supplement in Western Europe
GlaxoSmithKline plc
Bayer AG
Reckitt Benckiser Group PLC
Amway Corporation
Abbott Nutrition
Others
Segment Categorization of Dietary Supplement in Western Europe
By Form:
Soft Gel or Capsules
Confectionary Products
Gummies
Chews
Others
Pharmaceutical Products
Chewable Pills and Pills
Soft Gel
Powder
Liquid
By Ingredient:
Vitamins and Minerals
Amino Acids
Botanical Supplement
Others
By End Use:
Men
Women
Senior Citizen
Others
By Application:
Weight Loss
Sports Nutrients
General Well Being
Immune Health and Digestive Health
Bone and Joint Health
Heart Health
Others
By Distribution Channel:
Pharmacies Drug Store
Health and Beauty Stores
Immune Health and Digestive Health
Bone and Joint Health
Heart Health
Other
By Country:
Germany
Italy
France
United Kingdom
Spain
The Netherlands
BENELUX
Rest of Western Europe
Frequently Asked Questions
At What Rate is the Dietary Supplement Industry Growing in Western Europe?
The anticipated CAGR through 2033 is 8.2%.
How Big will the Dietary Supplement Industry be in Western Europe?
Demand for dietary supplement in Western Europe is expected to reach US$ 35,578.05 million by 2033.
What is the Key Strategy that Manufacturers in Western Europe are Adopting?
Manufacturers are turning to investment strategy to compete in the region.
Which Form of Dietary Supplement is Extensively Used?
Soft gels/pills is prominently consumed by population in Western Europe.
Which Ingredients Take up a Significant Share?
Amino acids take a considerable share of the dietary supplement industry.
Table of Content
1. Executive Summary
1.1. Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units pack) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Ingredients
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis By Ingredients , 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units pack) Analysis and Forecast By Ingredients , 2023 to 2033
5.3.1. Amino Acid
5.3.2. Animal Extract
5.3.3. Botanical Extract
5.3.4. Mineral
5.3.5. Nucleotide
5.3.6. Omega 3
5.3.7. Probiotics
5.3.8. Protein
5.3.9. Sugar
5.3.10. Vegetable Oil & Powder
5.3.11. Vitamin
5.3.12. Yeast Extract
5.4. Y-o-Y Growth Trend Analysis By Ingredients , 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Ingredients , 2023 to 2033
6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis By Form, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units pack) Analysis and Forecast By Form, 2023 to 2033
6.3.1. Soft Gel/Pills
6.3.1.1. Confectionery Products
6.3.1.2. Pharmaceuticals Products
6.3.2. Powder
6.3.3. Liquid
6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033
7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis By Application , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units pack) Analysis and Forecast By Application , 2023 to 2033
7.3.1. Weight Loss
7.3.2. Sports Nutrition’s
7.3.3. General Well-Beings
7.3.4. Immune & Digestive Health
7.3.5. Bone & Joint Health
7.3.6. Heart Health
7.3.7. Others Specific Requirements (Supplements ,Anti -Allergies & EyeHealth)
7.4. Y-o-Y Growth Trend Analysis By Application , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033
8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis By Country, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units pack) Analysis and Forecast By Country, 2023 to 2033
8.3.1. UK
8.3.2. Germany
8.3.3. Italy
8.3.4. France
8.3.5. Spain
8.3.6. Rest of Western Europe
8.4. Market Attractiveness Analysis By Country
9. UK Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Region
9.2.1.1. England
9.2.1.2. Scotland
9.2.1.3. Wales
9.2.1.4. Northern Ireland
9.2.2. By Ingredients
9.2.3. By Form
9.2.4. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Region
9.3.2. By Ingredients
9.3.3. By Form
9.3.4. By Application
9.4. Key Takeaways
10. Germany Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
10.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Region
10.2.1.1. North-east (Germany)
10.2.1.2. North-west (Germany)
10.2.1.3. Central (Germany)
10.2.1.4. South (Germany)
10.2.1.5. Other(Germany)
10.2.2. By Ingredients
10.2.3. By Form
10.2.4. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Region
10.3.2. By Ingredients
10.3.3. By Form
10.3.4. By Application
10.4. Key Takeaways
11. Italy Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
11.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Region
11.2.1.1. North (Italy)
11.2.1.2. Central (Italy)
11.2.1.3. South (Italy)
11.2.1.4. Islands (Italy)
11.2.2. By Ingredients
11.2.3. By Form
11.2.4. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Region
11.3.2. By Ingredients
11.3.3. By Form
11.3.4. By Application
11.4. Key Takeaways
12. France Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
12.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Region
12.2.1.1. Northern (France)
12.2.1.2. Central (France)
12.2.1.3. Southern (France)
12.2.1.4. Eastern (France)
12.2.2. By Ingredients
12.2.3. By Form
12.2.4. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Region
12.3.2. By Ingredients
12.3.3. By Form
12.3.4. By Application
12.4. Key Takeaways
13. Spain Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
13.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Region
13.2.1.1. Basque Country
13.2.1.2. Andalusia
13.2.1.3. Extremadura
13.2.1.4. Catalonia
13.2.1.5. Valencia
13.2.1.6. Rest of Spain
13.2.2. By Ingredients
13.2.3. By Form
13.2.4. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Region
13.3.2. By Ingredients
13.3.3. By Form
13.3.4. By Application
13.4. Key Takeaways
14. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
14.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Ingredients
14.2.2. By Form
14.2.3. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Ingredients
14.3.2. By Form
14.3.3. By Application
14.4. Key Takeaways
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Ingredients
15.3.3. By Form
15.3.4. By Application
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Amway Corp.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Glanbia PLC
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Abbott
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Bayer AG
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Pfizer Inc.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. ADM
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Nu Skin Enterprises, Inc.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. GlaxoSmithKline plc
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Bionova
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. Ayanda
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
16.1.11. Arkopharma
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.11.5.2. Product Strategy
16.1.11.5.3. Channel Strategy
17. Assumptions & Acronyms Used18. Research Methodology
